Alexander Polinsky - Net Worth and Insider Trading

Alexander Polinsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alexander Polinsky owns 3 companies in total, including Cleveland BioLabs Inc (CBLI) , AtheroNova Inc (AHROQ) , and Statera BioPharma Inc (STAB) .

Click here to see the complete history of Alexander Polinsky’s form 4 insider trades.

Insider Ownership Summary of Alexander Polinsky

Ticker	Comapny	Transaction Date	Type of Owner
CBLI	Cleveland BioLabs Inc	2014-06-11	director
AHROQ	AtheroNova Inc	2013-02-15	director
STAB	Statera BioPharma Inc	2014-06-11	director

Alexander Polinsky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alexander Polinsky Ownership Network

Ownership Network List of Alexander Polinsky

No Data

Ownership Network Relation of Alexander Polinsky

Alexander Polinsky Owned Company Details

What does Cleveland BioLabs Inc do?

Who are the key executives at Cleveland BioLabs Inc?

Alexander Polinsky is the director of Cleveland BioLabs Inc. Other key executives at Cleveland BioLabs Inc include Vice President of Finance Christopher Zosh , Principal Financial Officer John Edward Szydlo , and President & CMO Langdon L Miller .

Cleveland BioLabs Inc (CBLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cleveland BioLabs Inc (CBLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cleveland BioLabs Inc (CBLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cleveland BioLabs Inc (CBLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cleveland BioLabs Inc Insider Transactions

No Available Data

What does AtheroNova Inc do?

Who are the key executives at AtheroNova Inc?

Alexander Polinsky is the director of AtheroNova Inc. Other key executives at AtheroNova Inc include 10 percent owner Knoll Capital Management, Lp , 10 percent owner David Weiner , and 10 percent owner Woodman Management Corp .

AtheroNova Inc (AHROQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AtheroNova Inc (AHROQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AtheroNova Inc (AHROQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AtheroNova Inc (AHROQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

AtheroNova Inc Insider Transactions

No Available Data

What does Statera BioPharma Inc do?

Who are the key executives at Statera BioPharma Inc?

Alexander Polinsky is the director of Statera BioPharma Inc. Other key executives at Statera BioPharma Inc include director & Chief Operating Officer Taunia Markvicka , Chief Technology Officer Robert Buckheit , and Chief Legal Officer Mcavoy Cozette M. .

Statera BioPharma Inc (STAB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Statera BioPharma Inc (STAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Statera BioPharma Inc (STAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Statera BioPharma Inc (STAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Statera BioPharma Inc Insider Transactions

No Available Data

Alexander Polinsky Mailing Address

Above is the net worth, insider trading, and ownership report for Alexander Polinsky. You might contact Alexander Polinsky via mailing address: C/o Atheronova Inc., 2301 Dupont Drive Suite 525, Irvine Ca 92612.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.